Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium

American Journal of Pathology

Volumn 174, Issue 6, 2009, Pages 2000-2006

  Zhang, Xi ^a,b   Liang, Sharon X ^d   Jia, Lin ^a   Chen, Ning ^a,b   Fadare, Oluwole ^e,f   Schwartz, Peter E ^g   Kong, Beihua ^a   Zheng, Wenxin ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^e WILFORD HALL MEDICAL CENTER   (United States)

^f Mays Cancer Center at UT Health San Antonio   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; CONTROLLED STUDY; EARLY DIAGNOSIS; ENDOMETRIUM; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SEROUS CARCINOMA; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LATENT PRECANCER; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERUS;

EID: 67049159403     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081085     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer. J Clin 2007, 57:43-66
2. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983, 15:10-17 (Pubitemid 13194678)
3. Sherman ME: Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000, 13:295-308 (Pubitemid 30207514)
4. Hecht JL, Mutter GL: Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 2006, 10:4783-4791 (Pubitemid 46630943)
5. Zheng W, Schwartz PE: Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management. Gynecol Oncol 2005, 96:579-582 (Pubitemid 40255473)
6. Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ: Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 1995, 26:1260-1267
7. Carcangiu ML, Tan LK, Chambers JT: Stage IA uterine serous carcinoma: a study of 13 cases. Am J Surg Pathol 1997, 21:1507-1514 (Pubitemid 27528263)
8. Goff BA, Kato D, Schmidt RA, Ek M, Ferry JA, Muntz HG, Cain JM, Tamimi HK, Figge DC, Greer BE: Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol 1994, 54:264-268 (Pubitemid 24301898)
9. Lee KR, Belinson JL: Recurrence in noninvasive endometrial carcinoma. Relationship to uterine papillary serous carcinoma. Am J Surg Pathol 1991, 15:965-973
10. Sherman M, Bur ME, Kurman RJ: p53 in endometrial cancers and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 1995, 26:1268-1274
11. Silva EG, Jenkins R: Serous carcinoma in endometrial polyps. Mod Pathol 1990, 3:120-128
12. Sherman ME, Bitterman P, Rosenshein NB, Delgado G, Kurman RJ: Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992, 16:600-610
13. Zheng W, Khurana R, Farahmand S, Wang Y, Zhang ZF, Felix JC: p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma. Am J Surg Pathol 1998, 22:1463-1473
14. Fadare O, Liang SX, Ulukus EC, Chambers SK, Zheng W: Precursors of endometrial clear cell carcinoma. Am J Surg Pathol 2006, 30:1519-1530 (Pubitemid 44808788)
15. Liang SX, Chambers SK, Cheng L, Zhang S, Zhou Y, Zheng W: Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features. Int J Surg Pathol 2004, 12:319-331 (Pubitemid 39463501)
16. Zheng W, Liang SX, Yu H, Rutherford T, Chambers SK, Schwartz PE: Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features. Int J Surg Pathol 2004, 12:207-223 (Pubitemid 39063348)
17. Yi X, Zheng W: Endometrial glandular dysplasia and endometrial intraepithelial neoplasia. Curr Opin Obstet Gynecol 2008, 20:20-25
18. Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW, Lee Y: The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 2007, 19:3-9 (Pubitemid 46095865)
19. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD, Crum CP: A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 2007, 211:26-35 (Pubitemid 46092026)
20. Silverberg SG, Mutter GL, Kurman RJ, Kubik-Huch RA, Nogales F, Tavassoli FA: Tumors of the uterine corpus. Epithelial tumors and related lesions, In World Health Organization Classification of Tumors, Third Series, Edited by Tavassoli, F.A. and Devilee, P. Pathology and genetics: Tumors of the breast and female genital organs, IARC Press. Lyon 2003, pp 224-225
21. Jia L, Liu Y, Yi X, Miron A, Crum CP, Kong B, Zheng W: Endoemtrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma. Clin Cancer Res 2008, 14:2263-2269 (Pubitemid 351551056)
22. Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick L: p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997, 150:177-185 (Pubitemid 27027108)
23. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RA Jr, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD: Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005, 434:907-913 (Pubitemid 40559004)
24. Orlando FA, Tan D, Baltodano JD, Khoury T, Gibbs JF, Hassid VJ, Ahmed BH, Alrawi SJ: Aberrant crypt foci as precursors in colorectal cancer progression. J Surg Oncol 2008, 98:207-213
25. Cairns J: Mutation and cancer: the antecedents to our studies of adaptive mutation. Genetics 1998, 148:1433-1440 (Pubitemid 28180673)
26. Moolgavkar SH, Kundson AG: Mutation and cancer: a model for human carcinogenesis. J Natl Caner Inst (Bethesda) 1981, 66: 1037-1052 (Pubitemid 11063900)
27. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R: Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982, 6:93-108
28. Jackson AL, Loeb LA: The mutation rate and cancer. Genetics 1998, 148:1483-1490
29. Strong MS, Incze J, Vaughan CW: Field cancerization in the aerodigestive tract-its etiology, manifestation, and significance. J Otolaryngol 1984, 13:1-6 (Pubitemid 14161555)
30. Zheng W, Liang SX, Yi X, Ulukus EC, Davis J, Chambers SK: Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma. Int J Gynecol Pathol 2007, 26:38-52 (Pubitemid 46036958)
31. Mutter GL, Ince TA, Baak JPA, Kust G, Zhou X, Eng C: Molecular identification of latent precancers in histologically normal endometrium. Cancer Res 2001, 61:4311-4314 (Pubitemid 32685749)